Zoetis Inc. Reports $2.4B Revenue in Strong Third Quarter 2024 Performance
Zoetis Inc. (NYSE: ZTS) announced robust financial results for the third quarter of 2024, with revenue reaching $2.4 billion.
BTC$64,983.00+0.59%
ETH$1,925.50+2.97%
USDT$0.9992-0.01%
USDC$0.9999+0.00%
XRP$1.12+1.34%
SOL$77.77+0.90%
TRX$0.3246-0.24%
FIGR_HELOC$1.04-0.03%
HYPE$67.71+3.90%
DOGE$0.0742-0.44%
USDS$0.9998+0.01%
ZEC$573.55+5.03%
RAIN$0.0145-1.39%
LEO$9.81+2.54%
WBT$56.99+0.31%
BTC$64,983.00+0.59%
ETH$1,925.50+2.97%
USDT$0.9992-0.01%
USDC$0.9999+0.00%
XRP$1.12+1.34%
SOL$77.77+0.90%
TRX$0.3246-0.24%
FIGR_HELOC$1.04-0.03%
HYPE$67.71+3.90%
DOGE$0.0742-0.44%
USDS$0.9998+0.01%
ZEC$573.55+5.03%
RAIN$0.0145-1.39%
LEO$9.81+2.54%
WBT$56.99+0.31%
Fortis Inc. (TSX/NYSE: FTS) reported strong third-quarter performance, with net earnings of $420 million, or $0.85 per common share, driven by rate base expansion and favorable earnings in Arizona.
Zoetis Inc. (NYSE: ZTS) announced robust financial results for the third quarter of 2024, with revenue reaching $2.4 billion.
FIS reported a 7% increase in GAAP Diluted EPS to $0.45 and a significant 49% rise in adjusted EPS.
Freshpet, Inc. reported a strong third-quarter performance with net sales reaching $253.4 million, marking a 26.3% increase y/y.
Entegris, Inc. reported a 9% decrease in net sales for the third quarter of 2024, with adjusted sales showing a 7% year-over-year increase.
Charter Communications, Inc reported a strong performance in the third quarter of 2024, with a 1.6% increase in total revenue.
Cardinal Health's Q1 FY25 results revealed a 4% decline in total revenue but a 9% improvement in gross margin.
ExxonMobil's third-quarter earnings of $8.6 billion, or $1.92 per diluted share.
Chevron Corporation (NYSE: CVX) reported earnings of $4.5 billion, or $2.48 per diluted share, for the third quarter of 2024.
Uber exceeded Wall Street expectations but slower gross bookings growth puts pressure on stock price.
Eaton Corporation plc has reported record-breaking results for the third quarter of 2024, with an EPS of $2.53 and a third-quarter sales record of $6.3 billion.
Merck's third-quarter financial performance in 2024 showcased robust worldwide sales growth of 4%, reaching $16.7 billion.
The Cigna Group (NYSE: CI) has reported impressive financial results for the third quarter of 2024.